What's New in Hepatitis C: Current State of the Field and Future (Hepatitis C Treatment Options)

What's New in Hepatitis C: Current State of the Field and Future
Medscape News - The current standard of care for the treatment of previously untreated patients with chronic hepatitis C is a combination of once-weekly injection of pegylated interferon plus daily oral ribavirin. The treatment duration is dependent on HCV genotype

Potential strategy to improve T cell immunotherapy
RxPG - By http://www.dfci.harvard.edu/, Like boxers wearied by a 15-round bout, the immune system's CD8 T cells eventually become "exhausted" in their battle against persistent viral infection, and less effective in fighting the disease. In a study to be

Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after
BioMed Central - This study used data from the United States Renal Data System (USRDS), using standard analysis files (SAF's) as of May 2000. The USRDS, indirectly mandated by federal law, incorporates baseline and follow-up demographic and clinical data on all